Comparison of Splenectomy and Treatment Failure Incidence in Nonsplenectomized Patients with Immune Thrombocytopenia (ITP) Receiving Romiplostim or Medical Standard of Care: 1-Year Treatment and 6-Month Safety Follow-up.David J. Kuter, Dietmar Berger, Ralph V. Boccia et al.|Blood|2009Cited by 7